SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-004937
Filing Date
2021-01-28
Accepted
2021-01-28 16:36:45
Documents
3
Period of Report
2021-01-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea134100-8k_silopharma.htm 8-K 20903
2 SILO PHARMA, INC. 2020 OMNIBUS EQUITY INCENTIVE PLAN ea134100ex10-1_silopharma.htm EX-10.1 120688
3 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT, DATED JANUARY 18, 2021, BY AND BETWEEN ea134100ex10-2_silopharma.htm EX-10.2 19372
  Complete submission text file 0001213900-21-004937.txt   162518
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54872 | Film No.: 21565629
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl